Q2 2026 Holdings
Filed 2026-08-14 | 43 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $482.7M | 2,577,333 | 24.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $300.0M | 16,035,240 | 15.0% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $254.5M | 3,707,164 | 12.7% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $131.5M | 4,655,000 | 6.6% |
| Illumina Inc(ILMN) | COM | 452327109 | $93.2M | 530,000 | 4.7% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $73.0M | 88,783,856 | 3.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $63.1M | 1,175,000 | 3.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $52.6M | 2,045,000 | 2.6% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $48.6M | 1,545,361 | 2.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $46.3M | 1,350,000 | 2.3% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $40.3M | 1,050,000 | 2.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $36.6M | 665,000 | 1.8% |
| Personalis Inc(PSNL) | COM | 71535D106 | $34.2M | 2,550,000 | 1.7% |
| Grail Inc(GRAL) | COM | 384747101 | $32.8M | 480,000 | 1.6% |
| Guardant Health Inc(GH) | COM | 40131M109 | $27.8M | 185,000 | 1.4% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $25.2M | 843,857 | 1.3% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $24.3M | 700,000 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $22.6M | 75,000 | 1.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $22.1M | 3,250,000 | 1.1% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $20.1M | 1,550,000 | 1.0% |
| Septerna Inc(SEPN) | COM | 81734D104 | $18.5M | 553,268 | 0.9% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $17.7M | 645,690 | 0.9% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $17.6M | 400,000 | 0.9% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $16.2M | 276,308 | 0.8% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $14.4M | 1,250,000 | 0.7% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $11.7M | 3,167,175 | 0.6% |
| Absci Corporation(ABSI) | COM | 00091E109 | $11.3M | 973,260 | 0.6% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $10.6M | 50,000 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $8.4M | 470,000 | 0.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.9M | 150,000 | 0.3% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $6.0M | 355,000 | 0.3% |
| Moderna Inc(MRNA) | COM | 60770K107 | $5.3M | 75,000 | 0.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.8M | 65,000 | 0.2% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $4.5M | 186,014 | 0.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $3.0M | 1,228,190 | 0.2% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $2.4M | 148,333 | 0.1% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $2.2M | 282,312 | 0.1% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $1.4M | 445,000 | 0.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.2M | 723,767 | 0.1% |
| Kardigan Inc(KARD) | COM | 485925101 | $1.2M | 50,000 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $606.7K | 165,323 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $361.6K | 36,493 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $267.5K | 361,969 | 0.0% |